Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Health Technology Assessment (Winchester, England)|May 31, 2014
Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-oldsKarl G Nicholson, Keith R Abrams, Sally Batham, et al.
Infection Control and Hospital Epidemiology|January 31, 2022
FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency departmentChristopher T Mansbridge, Alex R Tanner, Kate R Beard, et al.
The Lancet. Infectious Diseases|December 21, 2010
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trialKarl G Nicholson, Keith R Abrams, Sally Batham, et al.
Trials|August 1, 2022
Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)Sondre Serigstad, Christian Ritz, Daniel Faurholt-Jepsen, et al.
The Lancet. Respiratory Medicine|October 11, 2020
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled studyNathan J Brendish, Stephen Poole, Vasanth V Naidu, et al.
JAMA Network Open|March 6, 2024
Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing: A Randomized Clinical TrialDagfinn L Markussen, Sondre Serigstad, Christian Ritz, et al.
The New England Journal of Medicine|May 13, 2026
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household ContactsFrederick G Hayden, Masaharu Shinkai, Tristan W Clark, et al.
JAMA Internal Medicine|March 4, 2024
Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-AnalysisTilmann Schober, Kimberly Wong, Gaëlle DeLisle, et al.
Viruses|April 30, 2021
Comparison of Serological Assays for the Detection of SARS-CoV-2 AntibodiesJoe James, Shelley Rhodes, Craig S Ross, et al.
The Journal of Infection|October 4, 2021
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countriesMaria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, et al.
Pageof 6